CELL THERAPEUTICS

Codice
CTIC.MI
Risorse esterne
Opinione della community
Prezzo Variazione Volume
2.742 -0.36 €
(-11.61%)
118365
P/E Obiettivo ad 1anno
0 0 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 54
Sell : 22

Marco Furio pierino sony249 Luca lolibe marco zorz Fabrizio Aasi

Commenti


Notizie

Sage Therapeutics (SAGE) versus Brainstorm Cell Therapeutics (BCLI) Financial Analysis - The Ledger Gazette

Sage Therapeutics (NASDAQ: SAGE) and Brainstorm Cell Therapeutics (NASDAQ:BCLI) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, ... Leggi

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Experiences Heavier than Usual Trading Volume - Modern Readers

Capricor Therapeutics, Inc. shares had a trading volume of 33,217K on Wednesday. Volume was up ... The Business's lead product candidate, the Cardiosphere-Derived Cells (CDCs), are the single cell monolayer product of the CSps. CDCs are small ... Leggi

Dimension Therapeutics, Inc. (NASDAQ:DMTX) Traded Well Above Its 50 Day Average - Highlight Press

Short traders are more bearish on shares of Dimension Therapeutics, Inc. of late as implied by the motion in short interest. The stock ... The Company uses mammalian cells in its manufacturing approach for its AAV-based product candidates. Its AAV ... Leggi

Juno Therapeutics, Inc. (NASDAQ:JUNO) Stock Traded 29.4 ... - Highlight Press

The stock last traded at $44.65 which is significantly higher than $34.50, the 50 day moving average and quite a bit higher than the 200 day moving average of ... Leggi

Somewhat Positive Press Coverage Somewhat Unlikely to Impact ... - The Ledger Gazette

Press coverage about Brainstorm Cell Therapeutics (NASDAQ:BCLI) has trended somewhat positive recently, Accern Sentiment reports. The research firm rates ... Leggi

Zacks: Analysts Expect Brainstorm Cell Therapeutics Inc. (BCLI) Will ... - StockNewsTimes

Brainstorm Cell Therapeutics logo Wall Street brokerages expect Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) to report earnings of ($0.10) per share for ... Leggi

Is Mirati Therapeutics, Inc. (NASDAQ:MRTX) Topping? - Stock News Union (blog)

Traders are active in Mirati Therapeutics, Inc. (NASDAQ:MRTX) and are sending the shares up over 2.0% on heavy volume as of 10:30 AM EST. Last Friday MRTX stock essentially doubled after the biotech company released a statement announcing positive ... Leggi

Contrasting Trillium Therapeutics (TRIL) & Its Peers - The Ledger ... - The Ledger Gazette

Trillium Therapeutics (NASDAQ: TRIL) is one of 93 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its peers? We will ... Leggi

Adaptimmune Therapeutics PLC (ADAP) Receiving Somewhat ... - The Ledger Gazette

Headlines about Adaptimmune Therapeutics PLC (NASDAQ:ADAP) have trended somewhat positive recently, Accern Sentiment reports. The research group ... Leggi

Mid-Day Market Update: Mirati Therapeutics Climbs Following ... - Benzinga

Midway through trading Friday, the Dow traded up 0.20 percent to 22247.46 while the NASDAQ rose 0.47 percent to 6459.03. The S&P also rose, gaining ...altro » Leggi